The Latest
-
Analysts Just Slashed Their Chembio Diagnostics, Inc. (NASDAQ:CEMI) EPS Numbers
-
AstraZeneca’s Wins FDA Priority Review For Heart Drug Brilinta
-
Walgreens Ends Buybacks, Cuts Jobs as Profit Misses; Shares Fall
-
What Kind Of Shareholders Hold The Majority In Arrowhead Pharmaceuticals, Inc.’s (NASDAQ:ARWR) Shares?